Delayed Open Conversion after Endovascular Abdominal Aortic Aneurysm: Device-specific Surgical Approach  by Marone, E.M. et al.
Delayed Open Conversion after Endovascular Abdominal Aortic Aneurysm:
Device-speciﬁc Surgical Approach
E.M. Marone, D. Mascia *, G. Coppi, Y. Tshomba, L. Bertoglio, A. Kahlberg, R. Chiesa
Vascular Surgery, Vita-Salute University, San Raffaele Scientiﬁc Institute, Milan, Italy* Co
Vascula
7130; f
E-ma
1078
Surgery
http:WHAT THIS PAPER ADDS
Endovascular treatment of abdominal aortic aneurysms is nowadays performed in many centers at high and low
volumes of activity. Often its failure can be treated only by surgical conversion. This work gives an overview of
the causes and the possibility of surgical management of abdominal aortic aneurysms after endovascular
treatment failure.Objectives: Despite several advances in endoluminal salvage for failed endovascular abdominal aortic repair
(EVAR), in our experience an increasing number of cases necessitate delayed open conversion (dOC).
Methods: EVAR patients requiring delayed (>30 days) conversion were prospectively collected in a computerized
database including demographics, details of aortoiliac anatomy, procedural and clinical success, and
postoperative complications.
Results: Between 2005 and 2011, 54 patients were treated for aortic stent-graft explantation. Indications
included 34 type I and III endoleaks, 13 type II endoleaks with aneurysm growth, 4 cases of material failures, and
3 stent-graft infections. All ﬁt-for-surgery patients with type I/III endoleak underwent directly dOC. Different
surgical approaches were used depending on the type of stent-graft.
Overall 30-day mortality was 1.9%. Overall morbidity was 31% mainly due to acute renal failure (13 cases). Mean
hospitalization was 6 days (range, 5e27 days). Overall survival at mean follow-up of 19 months was 78%.
Conclusions: In recent years, the use of EVAR has increased dramatically, including in young patients regardless of
their ﬁtness for open repair. dOC after endovascular abdominal aortic aneurysm seems to be a lifesaving
procedure with satisfactory initial and mid-term results.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Open conversionINTRODUCTION
In the last two decades, endovascular aortic repair (EVAR)
has been demonstrated to be a valid and safe alternative to
open repair (OR) in the treatment of infrarenal abdominal
aortic aneurysms, with reduced early morbidity and
mortality rates. However, the “Achilles’ heel” of EVAR
remains its long-term durability, and lifelong surveillance is
therefore mandatory.1e3
Secondary procedures are required in up to 27e30% of
patients following EVAR independent of the type of stent-
graft implanted, and are mainly carried out by endovascular
means.4,5 Delayed open conversion (dOC) with or withoutrresponding author. D. Mascia, IRCCS H. San Raffaele, Department of
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//dx.doi.org/10.1016/j.ejvs.2012.12.021stent-graft explant is usually left for cases not amenable to
endovascular techniques.
The aim of this study is to report the indications, tech-
nical aspects and outcomes of a single-center experience
with dOC after EVAR.METHODS
All EVAR patients who underwent delayed open conversion
(dOC) between January 2005 and December 2011 were
prospectively recorded in a computerized database. The
database included demographics, comorbid conditions and
aortoiliac anatomy (involvement of the abdominal aorta
alone or of the aorto-iliac segment).
dOC was deﬁned as total or partial stent-graft removal
after 30 days from the initial EVAR procedure with pros-
thetic graft reconstruction of the aortic anatomy.
Indications for open conversion were the presence of an
endoleak warranting treatment (not amenable to endo-
vascular repair), stent-graft infection and graft failure
(either limb thrombosis or stent-graft collapse). Patients
Table 1. Demographic data of patients undergoing conversion and
type of stent-graft removed.
Cardiovascular risk factors N ¼ 54
Age 73  5.6
Male sex 47 (87%)
Active smoking 15 (28%)
CAD 18 (33%)
COPD 14 (26%)
Hypertension 51 (95%)
Dyslipidemia 33 (61%)
Diabetes 15 (28%)
EVAR procedure details
AAA original diameter (mm) 53 (42e71)
Time from EVAR to dOC (months) 63 (3e102)
AAA diameter at dOC (mm) 58 (45e83)
Stent-graft type
Excluder 13 (24%)
Zenith 12 (22%)
AneuRx 10 (18%)
Talent 6 (12%)
Vanguard 4 (7%)
Anaconda 4 (7%)
Endurant 3 (6%)
Treovance 1 (2%)
Ovation 1 (2%)
CAD: coronary artery disease; COPD: chronic obstructive
pulmonary disease; EVAR: endovascular aortic repair; dOC:
delayed open conversion.
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be treated by standard endovascular techniques (i.e. prox-
imal aortic cuff, aorto-uniliac or bifurcated implant) due to
inadequate anatomy, and resulted as low-risk surgical
candidates, underwent directly dOC. Indication for treat-
ment in the case of a type II endoleak was an aneurysm
growth equal to or greater than 1 cm/year: dOC was per-
formed only in patients ﬁt for open surgery in whom
endoluminal attempts had already failed. Advanced endo-
vascular repair, in our daily clinical practice (fenestrated/
branched stent-graft or chimney/periscope implant), is
reserved for patients at high risk for open conversion and
not amenable for standard endovascular repair.
Data of the index EVAR operation were recorded, with
particular attention to the date of the initial EVAR, device
type and any secondary endovascular operation performed
during follow up. Intraoperative data such as cross-clamping
site, the extent of stent-graft removal, reconstruction tech-
nique, operative and cross-clamping time were recorded.
Operative outcome was analyzed in terms of mortality
and perioperative systemic morbidities (at 30 days) and any
intraoperative complications related to the surgical opera-
tion. Classiﬁcation, etiology, location, and clinical manifes-
tations were reported according to the Society for Vascular
Surgery Suggested Reporting Standards1 and to the Society
for Vascular Surgery/American Association for Vascular
Surgery (SVS/AAVS) medical comorbidity grading system.2
Follow up was performed in the outpatient clinic at 3, 6
and 12 months, and then annually if not otherwise required.
Results are expressed as mean  standard deviation for
continuous variables and as frequency and percentage for
categorical variables.
RESULTS
Between January 2005 and December 2011, 54 patients
underwent dOC at our institution. Forty-seven patients were
male (87%) and the mean age was 73  5.6 years. Complete
patient demographic data and comorbidities are presented in
Table 1. Mean aneurysm size increased by 1.1 cm
(range,1.2 to 4.5 cm) between the time of initial EVAR and
the time of surgical conversion. The average time from the
index EVAR operation to dOC was 63 months (range 3e102
months). Five patients (9.2%) had their conversion within 12
months of stent-graft deployment. The initial EVAR was
performed at our institution in 11 cases (20%).
The stent-graft removed was the AneuRx in 10, the Talent
in 6 and the Endurant in 3 cases (Medtronic, Santa Rosa, CA,
USA), the Excluder (W. L. Gore & Associates, Flagstaff, AZ,
USA) in 13 cases, the Zenith (Cook, Bloomington, IN, USA) in
12, the Vanguard (Boston Scientiﬁc, Natick, MA, USA) in 4,
the Anaconda (Vascutek, Inchinnan, UK) in 4, the Treovance
(Bolton Medical, Sunrise, FL, USA) in 1 and the Ovation
(TriVascular, Santa Rosa, CA, USA) in 1.Indications
Indication for dOC was endoleak in 47 cases (87%), device
failure in 4 (7.4%) and stent-graft infection in 3 (5.6%).The endoleak group included 34 type I and III endoleaks
and 13 type II with sac enlargement. Although a single
patient might present with more than one endoleak only
the most clinically relevant was considered as the indication
for dOC.
There were ﬁve primary type I endoleaks (i.e. endoleak
detected at the ﬁrst computed tomography control after
index EVAR), 19 newly detected type I endoleaks with
aneurysm progression and 10 type III endoleaks (six limb
disconnections, four stent fractures with fabric tear).
Before undergoing conversion, 27 patients (50%) were
submitted to at least one secondary endovascular procedure.
This group included all the type II endoleaks, nine type I and
six type III endoleaks. Secondary endovascular procedures
were 10 lumbar artery embolizations, one transcaval aneu-
rysm sack embolization, two CT-guided embolizations and 15
cases of additional extension/stent-graft deployment. In all
cases the procedures proved unsuccessful either immedi-
ately or at follow up. Three patients were submitted to
a secondary surgical procedure before conversion: two cases
of laparoscopic ligation of the inferior mesenteric artery and
one case of aneurysm sac fenestration.
The device failure group included three cases of graft
thrombosis and one case of stent-graft infolding with
collapse, while in the infection group all three cases were
related to erosion of the stent-graft into the duodenal wall.
An elective operation was performed in 47 patients (87%)
while in seven cases the operation was urgent (Fig. 2). This
group included two graft thromboses causing ischemia of the
lower limbs and ﬁve aneurysm ruptures (four contained).
E.M. Marone et al. 459Indications with the total number of patients and extent
of aortic involvement are summarized in Table 2.
Operative technique
A transperitoneal approachwasused in all the cases. Amidline
incision was used in 47 cases (87%) while a bilateral subcostal
incision with medial visceral rotation was used in 7 cases
(13%). Proximal cross-clamping was supraceliac in 14 cases
(26%), suprarenal in 15 (28%) and infrarenal in 25 (46%). In 10
cases of supraceliac clamping (18%), the renal arteries were
perfused with a cold solution (4 C Custodiol Histidinee
TryptophaneKetoglutarate solution). In 16 cases proximal
cross-clamping was placed at the level of either the bare stent
or of the ﬁrst covered stents of the stent-graft (Fig. 3) while in
18 cases the iliac limbs were clamped. In 3 patients both the
proximal and iliac segments of the stent-graft were clamped.
After incision of the aneurysm sack, complete removal of
the stent-graft was performed in 17 cases (Fig. 2). These
included all the cases of stent-graft infection. Special care
was taken in the removal of the stent-grafts in the case of
suprarenal ﬁxation. To reduce the risk of dissection at the
level of the renal artery ostia, the stent-graft was ﬁrst
pushed cranially and gently crushed to detach the proximal
ﬁxation hooks and barbs from the aortic wall. Only after this
initial step was the stent-graft retracted.
Partial removal of the stent-graft was performed in the
remaining 37 cases (Figs. 1 and 3). When possible, resection
of the stent-graft was always done at the level of the fabric
to reduce the risk that the cut stent struts would eventually
damage the new graft or the suture line. In the case that
the stent struts had to be cut, special attention was paid to
avoid direct impingement of the leftover spikes against the
new aortic tube-graft.
Reconstructions included 53 cases of in-situ prosthetic
repair (11 cases with aorto-aortic bypass and 42 cases withTable 2. Indications with the total number of patients and extent
of aortic involvement.
Indication Elective
treatment
N ¼ 47
Urgent
treatment
N ¼ 7
Aneurysm
extension
Endoleak
N [ 47
43 4 Aorta ¼ 31
Aorto-iliac ¼ 16
Type I 22 2 Aorta ¼ 15
Aorto-iliac ¼ 9
Type II 13 e Aorta ¼ 10
Aorto-iliac ¼ 3
Type III 8 2 Aorta ¼ 6
Aorto-iliac ¼ 4
Infection
N [ 3
2 1 Aorta ¼ 1
Aorto-iliac ¼ 2
Device failure
N [ 4
2 2 Aorta ¼ 3
Aorto-iliac ¼ 1
Graft
thrombosis
1 2 Aorta ¼ 3
Aorto-iliac ¼ 0
Graft infolding
with collapse
1 e Aorta ¼ 0
Aorto-iliac ¼ 1
Aorta ¼ aneurysm limited to the aortic segment; aorto-iliac:
aneurysm involving at least one common iliac artery.aorto-bifemoral bypass) and 1 case of extra-anatomic
bypass (axillo-bifemoral bypass) for an extensive infection of
the stent-graft with disruption of the duodenal wall. All in-
situ repairs were performed with a Dacron graft. In the case
of infected stent-grafts, a silver-coated Dacron graft was
used. The only case of extra-anatomic reconstruction was
completed with an expanded polytetraﬂuoroethylene
externally supported graft. The Dacron grafts were never
anastomosed solely to a leftover segment of stent-graft (if
present); a layer of aortic or iliac wall was always included
in the anastomoses. This was done to ﬁx the reconstruction
and avoid further complications due to late migration of the
remaining stent-graft.
Whenever possible, an aorto-aortic reconstruction was
chosen (Fig. 1). The use of an aorto-bifemoral bypass was
deemed necessary in all cases of iliac aneurysmal degenera-
tion. In ﬁve cases the aorto-bifemoral reconstruction was
used because of a damaged iliac wall after stent-graft limb
removal. Overall, aorto-bifemoral reconstruction was
preferred in the case of complete stent-graft explant while
aorto-aortic reconstruction was performed in most cases of
partial stent-graft explant: the association was not considered
statistically signiﬁcant (Fisher’s exact test). Aorto-biiliac
reconstruction was not used in this group because, during the
operation, the iliac wall was found unsuitable for anastomosis
due to ﬁbrosis and thinning caused by the stent-graft limbs.
In one patient who had his iliac limbs completely
removed, stenting of the common iliac was done before
awakening due to the presence of a ﬂow-limiting distal
dissection (a weak femoral pulse was detected at the end of
the intervention and control angiography was therefore
performed).
Mean operative time was 154  63 min, with aorto-
aortic reconstruction with infrarenal clamping requiring the
shortest operative time (mean, 118  14 min).Early outcomes
There was one case of perioperative death with an overall
mortality rate of 1.9% (1/54). This patient presented at our
Emergency Department with shock due to free rupture of
an abdominal aortic aneurysm and was treated with an
aortobifemoral bypass with supraceliac clamping (complete
removal of the stent-graft). He died in the Intensive Care
Unit on the ﬁrst postoperative day due to multiorgan
failure.
The overall systemic morbidity rate was 31% (17 cases).
Acute renal failure was the most common comorbidity with
13 cases (24%). In three cases (5.5%), oliguria was detected
at the end of the operation and was secondary to dissection
of the renal artery ostia after removal of the stent-graft
suprarenal ﬁxation. All three cases were submitted to
emergent angiography with rescue stenting. Complete
revascularization of both kidneys was possible in two
patients. The third patient had only one kidney revascular-
ized and postoperative temporary hemodialysis was
required. He was discharged with a mild impairment in
renal function (S-creatinine 2.1 mg/dL). All other patients
Figure 1. Preoperative CT scan with 3D and virtual angioscopy reconstruction showing distal migration of a bifurcated stent-graft with type
I endoleak (A): of note, the aneurysm reperfusion (arrow) and stent-graft misalignment. Intraoperative images showing complete removal
of the proximal component (B) with endoclamping of iliac branches (C) for distal component preservation and aortic reconstruction by
means of a straight tube graft (D).
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normalization at discharge.
There was one case (1.9%) of perioperative acute
myocardial infarction requiring emergent angioplasty andFigure 2. Preoperative CT scan of an urgent open conversion after EVA
infrarenal aortic cross-clamping and complete stent-graft removal (C).stenting. Three patients developed respiratory insufﬁciency
(5.5%). This latter group included one patient who devel-
oped perioperative pneumonia and was discharged with
home oxygen therapy.R with posterior rupture (A and B). Intraoperative image showing
Figure 3. Intraoperative images showing proximal component management with stent-graft cross-clamping and partial stent-graft removal
(A); of note proximal aortic reconstruction with end-to-end anastomosis between graft and stent-graft (B).
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cases (17%). There were one case of spleen lesion (1.9%)
and two cases of bowel injury (3.8%). The ﬁrst was treated
with splenectomy with spleen slices reimplanted in an
omental pouch while the second case required simple direct
suture without the need for bowel resection. There were
three cases of bleeding requiring operative revision (5.5%),
with one case needing double revision for persistent
bleeding from the proximal anastomosis. Three patients
(5.5%) required emergent lower limb revascularization for
acute limb ischemia. There were two cases of postoperative
early iliac artery thrombosis that were treated with balloon
thrombectomy and stenting of the common iliac. Both cases
occurred in patients who had complete removal of the iliac
limb of the stent-graft. The third case consisted of distal
embolization at the level of the popliteal artery and was
treated with embolectomy after surgical cutdown of the
proximal popliteal artery.
Complete outcomes related to the device type and
surgical technique are reported in Table 3.
Mean hospitalization was 6 days (range, 5e27 days) with
35 patients (65%) discharged to a center for cardiopulmo-
nary rehabilitation and the remaining patients discharged
home. No patient required admission to a long-term
nursing facility.
Late outcomes and follow up
Six patients did not attend regular visits to the outpatient
clinic and were lost to follow up. No other record could be
found in the hospital archive and these patients could not
be contacted by phone.
For the remaining 46 patients (85%) the overall survival
at mean follow up of 19 months (range, 5e63) was 78%(37/47). There was one aortic related death: a patient who
developed an aorto-enteric ﬁstula 4 years after dOC for
a type I endoleak and died with hemorrhagic shock before
any operation could be attempted. The remaining deaths
were due to cancer in three cases and myocardial infarction
in four. For two patients the cause of death could not be
assessed. All patients treated for an infected stent-graft did
not show any recurrence of infection. The two patients
treated with in-situ silver graft reconstruction were dis-
charged with long-term antibiotic therapy.
DISCUSSION
Since its ﬁrst report, two decades ago, EVAR has become
a valid and safe alternative to OR for abdominal aortic
aneurysms.3e5 The principal objective of EVAR is to prevent
death secondary to aneurysm rupture, but the goal is not
always achieved: as shown in the EUROSTAR registry,
aneurysm rupture occurs in 1.4% of patients in the ﬁrst year
after EVAR and in 0.6% of patients in the second year,6 with
a cumulative annual risk of 2% at 6 years.7 Another concern
is that secondary interventions, in order to achieve or
maintain aneurysm exclusion and prevent aneurysm
rupture, are proved to be more frequent in patients
undergoing EVAR than OR.8e10 For these reasons lifelong
CT-scan surveillance is nowadays strictly recommended
after EVAR.11,12
Although EVAR was initially performed only in high-risk
patients with severe comorbidities and contraindication for
OR, the indication range has since been expanded to
include average risk patients, mostly in low volume
centers.13
It is therefore redundant to say that young patients with
good life expectancy require a longer follow-up than older
Table 3. Outcomes of open conversion related to device type and surgical technique.
Device type
N ¼ 54
Stent-graft partial preservation
N ¼ 37
Proximal clamping site Aortic reconstruction Perioperative outcome
Proximal
N ¼ 24
Iliac limbs
N ¼ 13
SC
N ¼ 14
SR
N ¼ 15
IR
N ¼ 25
Ao-ao
N ¼ 11
Ao-bi
N ¼ 42
A.-bifem
N ¼ 1
Excluder
N ¼ 13
4 3 2 4 7 2 11 e 3 ARFs, 1 AMI, 1 bleeding
(double revision),
1 acute limb ischemia
Zenith
N ¼ 12
7 4 5 2 5 3 9 e 3 ARFs (2 renal arteries
dissection, 1 RI, 1 acute
limb ischemia
AneuRx
N ¼ 10
3 2 1 3 6 2 7 1 1 death, 2 ARF, 2 RI
Talent
N ¼ 6
4 1 2 2 2 1 5 e 2 ARFs (1 renal arteries
dissection), 1 spleen
injury, 1 bleeding
Endurant
N ¼ 3
2 1 1 1 1 1 2 e 1 bowel injury, 1 ARF
Vanguard
N ¼ 4
2 1 1 1 2 1 3 e 1 ARF, 1 bowel injury,
1 acute limb ischemia
Anaconda
N ¼ 4
1 1 1 1 2 1 3 e 1 ARF, 1 bleeding
Treovance
N ¼ 1
1 e 1 e e e 1 e Uneventful
Ovation
N ¼ 1
e e e 1 e e 1 e Uneventful
SC: supraceliac; SR: suprarenal; IR: infrarenal; Ao-ao: aorto-aortic; Ao-bi: aorto-bifemoral; A.-bifem: axillo-bifemoral; ARF: acute renal
failure; AMI: acute myocardial infarction; RI: respiratory insufﬁciency.
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a secondary intervention during follow up. Furthermore,
although most of the secondary procedures can be per-
formed via percutaneous interventional routes, a signiﬁcant
number of them require open conversion.6,7
Early open conversion (<30 postoperative days) is usually
the result of a technical misadventure such as iliac calciﬁ-
cation or tortuosity, renal artery occlusion, technical prob-
lems during stent-graft deployment, or immediate post-
procedure graft thrombosis.14 dOC (>30 postoperative
days) is most commonly due to aneurysm growth or rupture
caused by endoleaks, stent-graft migration or material
failure;6,7,15 other indications for dOC include stent-graft
infection and thrombosis.14 In our experience, the risk of
early open conversion has been reduced by accurate patient
selection and technical improvement, resulting in only 2
cases and conﬁrming that it represents a rare event.16 On
the contrary, as shown in recent literature, dOC occurs in up
to 22% of patients following EVAR, with an overall rate of
1.9%.15
dOC presents several technical issues:
1. Access: median laparotomy or subcostal laparotomy in
patients who often have already been operated can
be complicated by the elevated risk of intestinal or
ureteral injury;17 in the case of proximal neck
enlargement with visceral vessel involvement,
transperitoneal medial visceral rotation is mandatory to
obtain adequate exposure and proximal aortic control.
Thoraco-phreno-laparotomy may help in the case ofproximal aortic neck enlargement with visceral artery
involvement, but it was not performed in this series of
patients.
2. Aortic cross-clamping: suprarenal aortic cross-clamping
is usually performed in the case of dOC with
explantation of a suprarenal ﬁxation stent-graft.
Different authors have speculated that such
a complication may be related to the dislocation of
atherosclerotic debris from the pararenal aorta or
because of distortion of the ostia of visceral vessels
(especially the superior mesenteric artery) by the clamp:
as Chong et al.18 showed in their report, patients
undergoing suprarenal aortic cross-clamping experience
a higher rate of mesenteric ischemia secondary to
visceral malperfusion compared to patients undergoing
infrarenal clamping (2.3% vs 0.8%). Prolonged
suprarenal or supraceliac aortic cross-clamping needed
for complex dOC, especially in the case of a well
incorporated free-ﬂow and proximal stent, could be
associated with increased morbidity and mortality:
Lyden et al.19 reported a 20% mortality rate in patients
undergoing dOC with supraceliac cross-clamping. The
risk of acute postoperative renal failure, especially in
patients with preoperative impairment of renal function
and glomerular ﬁltration rate reduction, may be
higher.20,21 From our experience, in order to avoid
mesenteric and renal ischemia, we prefer to perform an
infrarenal cross-clamping as often as possible. When
a suprarenal or supraceliac cross-clamping is needed,
after stent-graft explantation, we usually move the
E.M. Marone et al. 463clamp position to the infrarenal aorta, limiting visceral
ischemic injury. In a case where infrarenal cross-
clamping is not possible, adequate renal protection with
cold crystalloid perfusions can be applied routinely in
order to reduce the damage caused by prolonged renal
ischemia.22
3. Stent-graft removal and aortic reconstruction:
paraphrasing Hamlet’s verses we can nowadays say:
“to explant or not to explant: that is the question”. As
the traditional approach for dOC entails aortic cross-
clamping, stent-graft removal and aortic reconstruction
with prosthetic grafts23 (Fig. 2), it is generally burdened
by high mortality and morbidity rates, as shown by May
et al.24 who reported a 17% mortality and 17% renal
failure rate, and by Harris et al.6 who reported, in the
EUROSTAR registry, 24% mortality in patients
undergoing elective dOC. Several techniques have been
described to perform stent-graft explantation: Kelso
et al.23 advocate a traditional “clamp and pull”
technique; Brinster et al.25 perform routinely stent-graft
removal also in the case of suprarenal ﬁxation, using
a wire cutter in a circumferential manner to release
barbs from the main body of the stent-graft thus
avoiding intimal injury (Fig. 3); Koning et al.26 proposed
to collapse the upper bare metal stent in a 20 mL
syringe as a “home-made” introducer sheath; some
authors proposed also that iced saline can be placed on
nitinol elements to help collapse to the predeployment
state.23 Recently, several authors have argued for partial
explant of the stent-graft or even for complete stent-
graft preservation, presenting good results in terms of
intraoperative morbidity and mortality,27 likely
attributable to less aortic dissection, shorter clamp time
and lower incidence of visceral ischemia secondary to
supraceliac cross-clamping. From our experience, we
prefer to perform a complete explant as frequently as
possible, depending on stent-graft features. In the case
of complete explant, we perform an aorto-aortic end-to-
end proximal anastomosis by a 2/0 or 3/0 polypropylene
suture reinforced with a Teﬂon felt. If a suprarenal
ﬁxation stent-graft needed to be converted, we used to
try a complete explant of the stent-graft with
a temporary short suprarenal clamping. More recently,
especially where a long proximal free-ﬂow with barbs
was encountered, we have performed a partial main
body explant, by means of a circumferential wire cutter,
of the ﬁrst proximal covered stent. The proximal
anastomosis is then performed between the stent-graft
with the aortic wall and the aortic graft through
a running 2/0 polypropylene suture reinforced with
several Teﬂon pledgets (Fig. 3). Distal aortic anastomosis
and iliac branch management is also an issue: we usually
perform an aorto-aortic reconstruction with end-to-end
anastomosis to the aortic bifurcation in the case of distal
component partial explant (Fig. 1). On the other hand,
an aorto-bifemoral reconstruction is preferred in
the case of iliac branch complete explant; in these
cases the aortic bifurcation is sutured by means ofa 2/0 polypropylene running suture reinforced through
a Teﬂon felt. We believe that complete stent-graft
removal should be the aim of these kinds of procedure
(Fig. 2), but we have observed that each patient
deserves a “tailored treatment” depending on stent-
graft characteristics, aortic disease, comorbidities
and age.
This study has several limitations. First, the low incidence
of dOC means that statistical signiﬁcance is difﬁcult to
obtain, limiting the results and conclusions of the study.
Second, this study evaluates patients who required dOC at
our Institution, but not all patients who underwent EVAR at
our Institution were reviewed: so we are unable, to date, to
assess the real risk of dOC for patients who we have
treated. Other potential confounding factors are that stent-
graft materials have improved, and ﬁrst generation stent-
grafts are now no longer available which may affect the
eventual conversion rates.
Last but not least, current clinical indications for EVAR
have progressively expanded over the years and, with
increased off-label use, anatomical suitability has been
stretched and redeﬁned: this should make us reﬂect on the
fact that the incidence of dOC could change in the future.
CONCLUSION
In recent years, the use of EVAR has increased dramatically.
The number of late complications has also increased and in
our experience a growing number of stent-grafts have been
explanted. dOC after endovascular abdominal aortic aneu-
rysm seems to be a lifesaving procedure, with satisfactory
initial and mid-term results, that is comparable to primary
open repair even if it is technically more challenging. Long-
term radiological surveillance is mandatory.CONFLICT OF INTEREST/FUNDING
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